Streetbeat News

Products Services

JAZZ

LGND

Ligand Pharmaceuticals (NASDAQ:LGND) announced that its partner Jazz Pharmaceuticals (NASDAQ:JAZZ) has received approval from the European Commission for Enrylaze, a treatment for acute lymphoblastic leukemia and lymphoblastic lymphoma. The approval expands the market for one of Ligand's key commercial-stage products. Ligand is eligible to receive milestone payments and tiered royalties based on worldwide net sales of any products resulting from its collaboration with Jazz, including Rylaze.

Portfolio Pulse from Benzinga Newsdesk

September 22, 2023 | 1:01 pm

AAPL

NVDA

QCOM

SWKS

Huawei has unveiled its 5G Kirin 9000s processor, which has been used in its Mate 60 smartphone series. The series has seen impressive sales in China, with over 300,000 units sold within the first two weeks. This marks Huawei's first venture into the 5G realm since U.S. sanctions disrupted its business three years ago. The company has also started shipping surveillance camera chips, showcasing its resilience in navigating U.S. export controls.

Portfolio Pulse from Anusuya Lahiri

September 22, 2023 | 12:58 pm

AZN

AstraZeneca's shares are trading higher following the announcement that datopotamab deruxtecan showed statistically significant and clinically meaningful progression-free survival benefit in patients with HR+ and HER2 low or negative breast cancer.

Portfolio Pulse from Benzinga Newsdesk

September 22, 2023 | 12:50 pm

AMZN

GOOG

GOOGL

NFLX

Amazon Prime Video, a service by Amazon.Com, Inc (NASDAQ:AMZN), plans to introduce limited advertisements to its content starting in early 2024. This move is expected to support and amplify content investments. Members desiring an ad-free experience can opt for it at an additional $2.99 per month in the U.S. The move marks intense competition in the streaming space ruled by Netflix Inc (NASDAQ: NFLX), and Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL) YouTube.

Portfolio Pulse from Anusuya Lahiri

September 22, 2023 | 12:46 pm

AAPL

Apple Inc. has launched its latest iPhone 15 series, with significant design changes and enhancements. The new series has sparked questions about its potential impact on holiday sales. While orders for the highest-end iPhone 15 models are backlogged until mid-November, other newly launched products received a more subdued response. Apple is optimistic about the new series reversing a trend of declining sales, especially with the iPhone 15 Pro featuring a significant design shift. Wall Street estimates for Apple's fourth-quarter revenue stand at $89.3 billion, with $43.6 billion projected to come from the iPhone.

Portfolio Pulse from Ananya Gairola

September 22, 2023 | 12:46 pm

BABA

MLGO

MicroAlgo Inc. announced a new backtracking search algorithm, causing its shares to surge by 42%. Alibaba Group Holding's shares also rose by 4.75% amid reports of its logistics unit, Cainiao Network Technology, preparing for a Hong Kong stock exchange debut with a minimum of $1 billion via share sale.

Portfolio Pulse from ryanfaloona@benzinga.com

September 22, 2023 | 12:46 pm

UBER

Uber Technologies, Inc. (NYSE:UBER) saw increased activity from options traders, with calls outpacing puts by over two to one. A risk reversal trade involved traders buying the November 47.5 calls by selling the 37.5 puts. Uber and Oracle announced a new offering called Collect and Receive, which connects retailers and consumers to enhance last mile delivery. Uber shares fell 4.2% to close at $44.60 on Thursday, but added 1.23% in Friday's premarket trading session.

Portfolio Pulse from Priya Nigam

September 22, 2023 | 12:42 pm

GOOG

GOOGL

Google, a subsidiary of Alphabet Inc., is rolling out a new Android 14 beta update for its Pixel smartphones. The update includes several new features such as the ability to check battery health and charge cycles, manually forcing aspect ratios for apps, and using Pixel phones as webcams. The stable version of Android 14 is expected to launch with the Google Pixel 8, scheduled for October 4.

Portfolio Pulse from Rounak Jain

September 22, 2023 | 12:39 pm

LLY

The U.S. FDA has approved Jardiance, a drug developed by Eli Lilly and Company (LLY), for the treatment of adults with Chronic Kidney Disease (CKD). The approval is based on the EMPA-KIDNEY phase III trial, which showed that Jardiance significantly reduced the risk of kidney disease progression and cardiovascular death in adults with CKD.

Portfolio Pulse from Benzinga Newsdesk

September 22, 2023 | 12:36 pm

ALV

Autoliv China, a subsidiary of Autoliv, Inc. (NYSE:ALV), has entered into a strategic collaboration with Great Wall Motor (GWM), a leading vehicle manufacturer in China. The partnership aims to foster innovation in the global automobile industry by jointly developing state-of-the-art technologies and new products with sustainable materials. One of the expected outcomes is the creation of innovative systems like an overhead passenger airbag and a 'zero-gravity seat' for self-driven vehicles.

Portfolio Pulse from Shivani Kumaresan

September 22, 2023 | 12:35 pm